The effect of L-carnitine on retinal ischemia-reperfusion injury was evaluated in guinea pigs. 90 min of pressure-induced retinal ischemia followed by 24 h of reperfusion was established in both eyes of 2 groups of animals receiving either L-carnitine (100 mg/kg repeated in 5 doses) or saline intraperitoneally. After enucleation of all the eyes, including those of a control group, malonyldialdehyde (MDA) levels and the thickness of the retinal tissue were measured in 3 groups. The mean MDA value and the tissue thickness of the L-carnitine-treated group were statistically insignificant versus the control group (p > 0.05 and p > 0.05, respectively). However, these values were significantly different in the group receiving saline versus the control group and that receiving L-carnitine (p < 0.001, p < 0.001 and p < 0.001, p < 0.001 respectively). L-Carnitine might be an alternative drug for ischemia-reperfusion injury of the retina.

Keywords:
L-Carnitine, Ischemia-reperfusion injury, Retina, Guinea pig
1.
Droy-Lefaix MT, Szabo ME, Doly M: Ischemia and reperfusion-induced injury in rat retina obtained from normotensive and spontaneously hypertensive rats: Effects of free radical scavengers. Int J Tissue React 1993;15:85–92.
2.
Ophir A, Berenshtein E, Kitrossky N, Averbukh E: Protection of the transiently ischemic cat retina by zinc-desferrioxamine. Invest Ophthalmol Vis Sci 1994;35:1212–1222.
3.
Faberowski N, Stefannson E, Davidson RC: Local hypothermia protects the retina from ischemia. Invest Ophthalmol Vis Sci 1989;87:2309–2313.
4.
Hayreh SS, Kolder HF, Weingeist TA: Central retinal artery occlusion and retinal tolerance time. Invest Ophthalmol Vis Sci 1989;87:75–78.
5.
Hearse DJ: Reperfusion induced injury: A possible role of oxidant stress and its manipulation. Cardiovasc Drug Ther 1991;5:225–236.
6.
Tosaki A, Blasig IE, Pali T, Ebert B: Heart protection and radical trapping by DMPO during reperfusion in isolated working rat hearts. Free Radic Biol Med 1990;8:363–372.
7.
Ernester L: Biochemistry of reoxygenation injury. Crit Care Med 1988;16:942–953.
8.
McCord JM: Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159–163.
9.
Halliwel B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 2. Midsomer Norton, Bookcraft, 1989.
10.
Cadenas E: Biochemistry of oxygen toxicity. Annu Rev Biochem 1989;58:79–110.
11.
Laschi R: L-Carnitine and Ischemia: A Morphological Atlas of the Heart and Muscle, ed 1. Bologna, Fondazione Sigma-Tau, 1987.
12.
Siliprandi N, Ciman M, Sartorelli L: Myocardial carnitine transport; in Stam H, Van Der Vusse CJ (eds): Lipid Metabolism in the Normoxic and Ischemic Heart. Darmstadt, Steinkopff, 1987, pp 53–62.
13.
Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
14.
Szabo ME, Droy-Lefaix MT, Doly M, Carre C, Braquet P: Ischemia and reperfusion induced histologic changes in the rat retina. Invest Ophthalmol Vis Sci 1991;32:1471–1478.
15.
Granger DN, Rutili G, McCord JM: Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22–29.
16.
Szabo ME, Droy-Lefaix MT, Doly M, Braquet P: Modification of ischemia/reperfusion induced ion shifts (Na+, K+, Ca2+ and Mg2+) by free radical scavengers in rat retina. Ophthalmic Res 1993;25:1–9.
17.
Nayak MS, Kita M, Marmor MF: Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase. Invest Ophthalmol Vis Sci 1993;34:201–2022.
18.
Gupta LY, Marmor MF: Mannitol, dextromethorphan and catalase minimize ischemic damage to retinal pigment epithelium and retina. Arch Opthalmol 1993;111:383–388.
19.
Peachey NS, Green DJ, Pibbs H: Ocular ischemia and effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye. Invest Opthalmol Vis Sci 1993;34:57–66.
20.
Weber M, Said SM, Hicks D, Dreyfus H, Sahel JA: Monosialoganglioside GM1 reduces ischemia induced injury in the rat retina. Invest Opthalmol Vis Sci 1996;37:266–274.
21.
Di Giacomo C, Latteri F, Fichera C, Sorrenti V, Campisi A, Castorina C, Russo A, Pinturo R, Vanella A: Effect of acetyl-L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscles. Neurochem Res 1993;18:1157–1162.
22.
Packer L, Valenza M, Serbinova E, Starke-Reed P, Frost K, Kagan V: Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biochem Biophys 1991;28:533–537.
23.
Williamson JR, Arrigoni-Martelli E: The roles of glucose induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular disfunction. Int J Clin Pharmacol 1992;12:247–252.
24.
Visioli O, Pasini E, De Giuli F, Ferrari R: Molecular mechanism of action of L-carnitine in the treatment of myocardial disorders at the experimental level; in Ferrari R, DiMauro S, Sherwood G (eds): L-Carnitine and Its Role in Medicine. London, Academic Press, 1992, pp 237–263.
25.
Liedtke AJ, Nellis SH: Effects of carnitine in ischemic and fatty acid supplemented swine heart. J Clin Invest 1979;64:440–444.
26.
Liedtke AJ, Stephen H, Nellis SH, Whitesell LF: Effects of carnitine isomers on fatty acid metabolism in ischemic swine heart. Circ Res 1981;4:859–866.
27.
Atalla LR, Sevanian A, Rao NA: Immunohistochemical localisation of glutathinone peroxidase in ocular tissues. Curr Eye Res 1988;7:1023–1027.
28.
Tsai LY, Lee KT, Tsai SM, Lee SC, Yu HS: Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice. Clin Chim Acta 1993;215:41–50.
29.
Hughes WF: Quantification of ischemic damage in the rat retina. Exp Eye Res 1991;53:573–582.
30.
Kozak Y, Nordman JP, Faure JP, Rao NA, Marak GE: Effect of antioxidant enzymes on experimental uveitis in rats. Ophthalmic Res 199;21:230–234.
31.
Hayreh SS, Podhajksy P: Ocular neovascularisation with retinal vascular occlusion. Arch Ophthalmol 1982;100:1585–1589.
32.
Sies H: Oxidative stress: From basic research to clinical application. Am J Med 1991;91:315–385.
33.
Johnson NF, Foulds WS: The effects of total acute ischemia on the structure of the rabbit retina. Exp Eye Res 1978;27:45–59.
34.
Crosson CR, Willis CA, Potter DE: Effect of the calcium antagonist, nifedipine on ischemic retinal disfunction. J Ocul Pharmacol 1990;6:293–299.
35.
Takahashi K, Lamm TT, Edward DP, Buchi ER, Tso MOM: Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol 1992;110:862–870.
36.
Shakib M, Ashton N: Part II: Ultrastructural changes in focal retinal ischemia. Br J Ophthalmol 1966;50:325–384.
37.
Hinder RA, Stein HJ: Oxygen derived free radicals. Arch Surg 1991;126:104–106.
38.
McCord JM: The biochemistry and pathophysiology of superoxide. Physiologist 1983;26:156–158.
39.
Otamiri T: Oxygen radicals, lipid peroxidation and neutrophil infiltration after small intestinal ischemia and reperfusion. Surgery 1989;105:593–597.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.